In comparison to the group without AT1 peptide (AMO-1-NPs), the treatment of AT1-AMO-1-NPs showed a cardioprotection capacity by inhibiting apoptosis in the infarct border zone of the post-MI mice and reducing the infarct area. Here, AGTR1 is linked to myocardial infarction.